EMPASUS-M® Tablets
Empagliflozin 10 mg + Metformin 500 mg (SR)
Advanced Dual-Action Formulation for Type 2 Diabetes Mellitus
Description
Product Specifications
| Specification | Details |
|---|---|
| Brand Name | EMPASUS-M® |
| Product Type | Prescription Medicine |
| Therapeutic Category | Antidiabetic |
| Indication | Type 2 Diabetes Mellitus |
| Dosage Form | Tablet |
| Empagliflozin | 10 mg |
| Metformin Hydrochloride SR | 500 mg |
| Formulation | Sustained Release |
| Administration | Oral |
| Dosing shown on artwork | Once daily |
| Pack Size shown | 10 × 10 Tablets |
| Primary Action | Glycemic control |
| SGLT2 Component | Empagliflozin |
| Biguanide Component | Metformin |
| Target Population | Adults with Type 2 Diabetes Mellitus |
| Prescription Status | Prescription medicine |
